02162.HK
Keymed Biosciences Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 79.75
−0.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 25.18x
- P/E 2027E
- —
- P/E 2028E
- 49.29x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.98x
- PEG TTM
- —
- Price / book
- 5.10x
- Price / sales
- 12.05x
- Price / cash flow
- -20.97x
Enterprise value
- Enterprise value
- HKD 20.9B
- EV / sales
- 10.55x
- EV / EBITDA
- -21.38x
- EV / EBIT
- -18.60x
- Market cap
- HKD 23.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026